Navigation Links
Ukrainian Government Unit Sues in U.S. - Alleges Corrupt Scheme in Vaccine Purchases
Date:9/17/2010

PORTLAND, Ore., Sept. 17 /PRNewswire/ -- A unit of the Government of Ukraine today filed suit in federal court in Portland, Oregon against a U.S. company that is alleged to be part of an international conspiracy involving the fraudulent sale of vaccines and other pharmaceuticals.  The case was brought by Ukrvaktsina – the Ukrainian state-owned enterprise responsible for the procurement and storage of medicines and medical supplies for Ukraine's Ministry of Health.  The suit seeks damages for fraud, conspiracy and violations of the Racketeer Influenced and Corrupt Organizations Act ("RICO").  

The complaint alleges that from 2008 through 2009, the U.S. company – Olden Group, LLC, which is owned by offshore companies registered in Belize and the South Pacific island of Niue – played a key role in a conspiracy to unlawfully mark-up the price of millions of doses of vaccines which were intended for use in the Ukrainian public health system.  According to the complaint, Olden Group and the other conspirators used offshore shell companies to launder the cash proceeds of the scheme through banks in Latvia, the United States and elsewhere.  The scheme is alleged to have involved more than US$50 million in payments by Ukrvaktsina and the Government of Ukraine over a period of several years.  

This case represents the first court action arising out of a comprehensive anti-corruption investigation ordered by the Cabinet of Ministers of Ukraine in May 2010.  That investigation has been led by the Washington, D.C. law firm of Trout Cacheris, PLLC, in collaboration with the international investigative firm Kroll, Inc. and the law firm Akin Gump Strauss Hauer & Feld, LLP.

Speaking from Washington, D.C., Plato Cacheris said, "The action that was filed today is in the courts of the United States because the Government of Ukraine believes that these cases should be litigated in a legal arena that is transparent and will assure the best prospect of recovery."

Co-counsel Mark MacDougall of Akin Gump Strauss Hauer and Feld, LLP added, "The leadership in Kiev is committed to exposing corruption no matter where the trail may lead.  This case is just the first public action to be taken outside Ukraine as a result of the Government's extensive anti-corruption investigation, but will likely not be the last."  

The lawsuit was filed jointly by Trout Cacheris, PLLC and Akin Gump Strauss Hauer and Feld, LLP.


'/>"/>
SOURCE Trout Cacheris, PLLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
2. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
3. Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
4. The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Countrys Biological Preparedness
5. One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak
6. Southern Research to Play Key Role in the Federal Governments Search for New Cancer Therapies
7. BioCryst Clarifies Government Declaration Regarding Peramivir
8. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
9. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
10. Malaria Experts Call on Federal Government to Increase Support for Research and Development
11. Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017 Research ... Markets for Emerging Medical Device Technologies" report to their ... ... valves, open procedures, general instruments, non-drug coated implantables, large endoscopes, ... been in use over the last two to three decades ...
(Date:2/16/2017)... Feb. 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... company, today announced that executive management will participate in ... held February 22-23, 2017. Adrian Adams , Chief ... at 1:35 p.m. local time on Wednesday, February 22, ... for the event may be accessed from the Investors ...
(Date:2/16/2017)... , Feb. 16, 2017  AcelRx Pharmaceuticals, Inc. ... company focused on the development and commercialization of ... pain, announced that Vincent J. Angotti ... member of the company,s board of directors, effective ... two decades of experience leading executive and commercial ...
Breaking Medicine Technology:
(Date:2/17/2017)... , ... February 17, 2017 , ... ... brings its educational assistance management solution to the exhibit floor for the ... Orlando, Fla. , From Feb. 19–23, 2017, more than 40,000 healthcare industry ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... Dr. Carol Francis' goals for each and every seminar, session and ... Francis will demonstrate five different brainwave tools which help energize creativity, focus mental ...
(Date:2/17/2017)... ... 2017 , ... Qualis Health, one of the nation's leading ... DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that are ... award categories, highlighting four of the organization’s current programs:, , ...
(Date:2/17/2017)... WASHINGTON (PRWEB) , ... February 17, 2017 , ... ... communities by fall 2017 season , Trinity Health and the U.S. Soccer Foundation ... for Success program in underserved communities. Soccer for Success, the Foundation’s soccer mentoring ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended CHI's 8th ... of clinical trial planning and management. Pharmica discussed the importance of effective project ... attendees stopping by Pharmica’s booth were able to demo its cloud-based Resource ...
Breaking Medicine News(10 mins):